Transition from minimal change disease to focal segmental glomerulosclerosis related to occupational exposure: A case report

BACKGROUND Although minimal change disease (MCD) and focal segmental glomerulosclerosis (FSGS) have been described as two separate forms of nephrotic syndrome (NS), they are not completely independent. We report a case of a patient transitioning from MCD to FSGS, review the literature, and explore the relationship between the two diseases. CASE SUMMARY A 42-year-old male welder, presenting with lower extremity edema and elevated serum creatinine, was diagnosed with NS and end-stage kidney disease (ESKD) based on laboratory test results. The patient had undergone a kidney biopsy for NS 20 years previously, which indicated MCD, and a second recent kidney biopsy suggested FSGS. The patient was an electric welder with excessive levels of cadmium and lead in his blood. Consequently, we suspect that his aggravated pathology and occurrence of ESKD were related to metal nephrotoxicity. The patient eventually received kidney replacement therapy and quit his job which involved long-term exposure to metals. During the 1-year follow-up period, the patient was negative for metal elements in the blood and urine and recovered partial kidney function. CONCLUSION MCD and FSGS may be different stages of the same disease. The transition from MCD to FSGS in this case indicates disease progression, which may be related to excessive metal contaminants caused by the patient’s occupation.

[1]  G. Makris,et al.  Clinical Characteristics and Outcomes of Adults with Nephrotic Syndrome Due to Minimal Change Disease , 2021, Journal of clinical medicine.

[2]  G. Dworacki,et al.  Lithium toxicity and the kidney with special focus on nephrotic syndrome associated with the acute kidney injury: A case‐based systematic analysis , 2021, Journal of applied toxicology : JAT.

[3]  Hefa Cheng,et al.  Associations between exposure to heavy metals and the risk of chronic kidney disease: a systematic review and meta-analysis , 2021, Critical reviews in toxicology.

[4]  Liliane Silvano Araújo,et al.  In situ evaluation of podocytes in patients with focal segmental glomerulosclerosis and minimal change disease , 2020, PloS one.

[5]  K. Phelps,et al.  Cadmium and Lead Exposure, Nephrotoxicity, and Mortality , 2020, Toxics.

[6]  G. Fernández-Juárez,et al.  Focal Segmental Glomerulosclerosis: State-of-the-Art and Clinical Perspective , 2020, Nephron.

[7]  A. Bomback,et al.  Approach to Diagnosis and Management of Primary Glomerular Diseases Due to Podocytopathies in Adults: Core Curriculum 2020. , 2020, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[8]  L. Bu,et al.  Immunoglobulin G/albumin staining in tubular protein reabsorption droplets in minimal change disease and focal segmental glomerulosclerosis. , 2020, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[9]  Y. Shibagaki,et al.  Morphological Features of Minimal Change Disease and Focal Segmental Glomerulosclerosis Using Repeat Biopsy and Parietal Epithelial Cell Marker , 2020, Kidney Diseases.

[10]  Sohee Oh,et al.  Urinary myo-inositol is associated with the clinical outcome in focal segmental glomerulosclerosis , 2019, Scientific Reports.

[11]  O. Mehrpour,et al.  Impact of chronic lead exposure on liver and kidney function and haematologic parameters , 2018, Basic & clinical pharmacology & toxicology.

[12]  A. Ricardo,et al.  Associations between blood cadmium concentration and kidney function in the U.S. population: Impact of sex, diabetes and hypertension , 2019, Environmental research.

[13]  L. Greenbaum,et al.  Nephrotic Syndrome. , 2019, Pediatric clinics of North America.

[14]  M. Schiffer,et al.  Minimal-change-Glomerulonephritis und fokal-segmentale Glomerulosklerose , 2019, Der Internist.

[15]  J. Deegens,et al.  The Clinical Course of Minimal Change Nephrotic Syndrome With Onset in Adulthood or Late Adolescence: A Case Series. , 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[16]  F. Emma,et al.  Minimal Change Disease. , 2017, Clinical journal of the American Society of Nephrology : CJASN.

[17]  B. Smeets,et al.  Minimal change disease and idiopathic FSGS: manifestations of the same disease , 2016, Nature Reviews Nephrology.

[18]  Nicolas Wieder,et al.  Calcium, TRPC channels, and regulation of the actin cytoskeleton in podocytes: towards a future of targeted therapies , 2015, Pediatric Nephrology.

[19]  S. Shankland,et al.  Inducible rodent models of acquired podocyte diseases. , 2009, American journal of physiology. Renal physiology.

[20]  J. Nagy,et al.  [Focal segmental glomerulosclerosis]. , 2008, Orvosi hetilap.

[21]  P. Devarajan,et al.  Single and combination toxic metal exposures induce apoptosis in cultured murine podocytes exclusively via the extrinsic caspase 8 pathway. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[22]  W. Smoyer,et al.  Differential induction of podocyte heat shock proteins by prolonged single and combination toxic metal exposure. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.

[23]  A. Fogo Minimal change disease and focal segmental glomerulosclerosis. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[24]  A. Tejani,et al.  Predictive Value of Repeat Renal Biopsies in Children with Nephrotic Syndrome , 2000, Nephron.